These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23825401)

  • 21. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth disease: an update.
    Shy ME
    Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axons.
    Thaxton C; Pillai AM; Pribisko AL; Labasque M; Dupree JL; Faivre-Sarrailh C; Bhat MA
    J Neurosci; 2010 Apr; 30(14):4868-76. PubMed ID: 20371806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
    Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
    J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
    Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME
    Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
    J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.
    Joseph S; Vingill S; Jahn O; Fledrich R; Werner HB; Katona I; Möbius W; Mitkovski M; Huang Y; Weis J; Sereda MW; Schulz JB; Nave KA; Stegmüller J
    J Neurosci; 2019 Jul; 39(28):5606-5626. PubMed ID: 31085610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
    Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
    J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system.
    Chang Y; Zhu J; Li X; Deng Y; Lai B; Ma Y; Tong J; Liu H; Li J; Yang C; Chen Q; Lu C; Liang Y; Qi S; Wang X; Kong E
    Signal Transduct Target Ther; 2024 Sep; 9(1):254. PubMed ID: 39327467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
    Adlkofer K; Frei R; Neuberg DH; Zielasek J; Toyka KV; Suter U
    J Neurosci; 1997 Jun; 17(12):4662-71. PubMed ID: 9169527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.
    Guerrero-Valero M; Grandi F; Cipriani S; Alberizzi V; Di Guardo R; Chicanne G; Sawade L; Bianchi F; Del Carro U; De Curtis I; Pareyson D; Parman Y; Schenone A; Haucke V; Payrastre B; Bolino A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small axons relative to number of myelin lamellae in Charcot-Marie-Tooth disease 1A with peripheral myelin protein 22 gene duplication.
    Ohnishi A; Yamamoto T; Ikeda M
    J UOEH; 2000 Jun; 22(2):107-17. PubMed ID: 10862406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.
    Previtali SC; Quattrini A; Fasolini M; Panzeri MC; Villa A; Filbin MT; Li W; Chiu SY; Messing A; Wrabetz L; Feltri ML
    J Cell Biol; 2000 Nov; 151(5):1035-46. PubMed ID: 11086005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
    Lancaster E; Li J; Hanania T; Liem R; Scheideler MA; Scherer SS
    Exp Neurol; 2018 Oct; 308():13-25. PubMed ID: 29940160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
    Groh J; Heinl K; Kohl B; Wessig C; Greeske J; Fischer S; Martini R
    Hum Mol Genet; 2010 Sep; 19(18):3530-43. PubMed ID: 20591826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DHTKD1 Deficiency Causes Charcot-Marie-Tooth Disease in Mice.
    Xu WY; Zhu H; Shen Y; Wan YH; Tu XD; Wu WT; Tang L; Zhang HX; Lu SY; Jin XL; Fei J; Wang ZG
    Mol Cell Biol; 2018 Jul; 38(13):. PubMed ID: 29661920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.